Department of Health (DOH) has released the list of VAT exempt medicines for diabetes, hypertension and high cholesterol. This is lieu of their Drug Price Watch program.
In their official Facebook account, DOH said that included in the list are more than 3,500 medicines. A chart was posted showing comparison of prices from different hospital sector (public/DOH hospitals nationwide vs. private) and several drug stores (The Generics Pharmacy, Generika, South Star Drug, Watsons, and Mercury Drug).
Potential savings for buying these VAT exempt medicines was also illustrated in the said chart.
As stated in the list, the price range represented is based on the cheapest to the most expensive drug available in the market.The research was conducted by the DOH Monitoring Team during the period of December 1-21, 2018. Therefore prices may have changed without prior notice.
The following are some of the medicines mentioned in the post.
Anti-Hypercholesterolmia- Simvastatin, Rosuvastatin, Atorvastatin
Anti-Hypertension- Amlodipine, Losartan, Metoprolol, Enalapril
Anti-Thrombotic- Aspirin, Clopidogrel
Anti-Diabetic- Glicazide, Metformin, Regular Insulin, Isophane (NPH) Insulin
DOH said that the removal of VAT in these medicines was brought about by the implementation of TRAIN ( Tax Reform for Acceleration and Inclusion) law.
A link was provided in the FB post to access the complete list of the VAT exempt medicines/
Here is the complete post.